CD3 directed bispecific antibodies induce increased lymphocyte-endothelial cell interactions in vitro

British Journal of Cancer

Volumn 82, Issue 2, 2000, Pages 472-479

  Molema, G ^a,b   Cohen Tervaert, J W ^c   Kroesen, B J ^a   Helfrich, W ^a   Meijer, D K F ^b   De Leij, L F M H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Department of Clinical Immunology ^*  (Netherlands)

Author keywords

Adhesion; CD3 directed bispecific antibody; Immunotherapy; In vitro; PBMC; Transendothelial migration

Indexed keywords

BISPECIFIC ANTIBODY; CD3 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPITHELIAL GLYCOPROTEIN 2; GAMMA INTERFERON; GLYCOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BLOOD LEVEL; CANCER IMMUNOTHERAPY; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE; LYMPHOCYTOPENIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033985054     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0945     Document Type: Article

References (27)

1. Buysmann S, Bemelman FJ, Schellekens PT, Van Kooyk Y, Figdor CG and ten Berge IJ (1996) Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3. Blood 87: 404-411
2. Clark M, Bindon C, Dyer M, Friend P, Hale G, Cobbold S, Calne R and Waldmann H (1989) The improved lytic function and in vivo efficacy of monovalent monoclonal CD3 antibodies. Eur J Immunol 19: 381-388
3. de Gast GC, Haagen IA, van Houten AA, Klein SC, Duits AJ, de Weger RA, Vroom TM, Clark MR, Phillips J, van Dijk AJ, et al (1995) CD8 T cell activation after intravenous administration of CD3 x CD19 bispecific antibody in patients with non-Hodgkin lymphoma. Cancer Immunol Immunother 40: 390-396
4. de Leij L, Helfrich W, Stein R and Mattes MJ (1994) SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2. Int J Cancer 8: 60-63
5. Demanet C, Brissinck J, De Jonge J and Thielemans K (1996) Bispecific antibody mediated immunotherapy of the BCL1 lymphoma: increased efficacy with multiple injections and CD28-induced costimulation. Blood 87: 4390-4398
6. 2+/calmodulin-dependent kinase type IV is involved in the CD5-mediated signalling pathway in human T lymphocytes. J Biol Chem 272: 31809-31820
7. Gringhuis SI, de Leij LFMH, Coffer PJ and Vellenga E (1998b) Signalling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, VaV, and Racl in human mature T lymphocytes. Mol Cell Biol 18: 1725-1735
8. Helfrich W, Kroesen BJ, Roovers RC, Westers L, Molema G, Hoogenboom HR and de Leij L (1998) Construction and characterization of a bispecific diabody for retargeting T-cells to human carcinomas. Int J Cancer 76: 232-239
9. Janssen RAJ, Kroesen BJ, Buter J, Mesander G, Sleijfer DT, The TH, Mulder NH and de Leij L (1995) Immunomodulatory effects of intravenous BIS-1 F(ab′)2 administration in renal cancer patients. Br J Cancer 72: 795-799
10. Kroesen BJ, ter Haar A, Spakman H, Willemse P, Sleijfer DT, de Vries EGE, Mulder NH, Berendsen HH, Limburg PC, The TH and de Leij L (1993) Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells. Cancer Immunol Immunother 37: 400-407
11. Kroesen BJ, Buter J, Sleijfer DT, Janssen RAJ, van der Graaf WTA, The TH, de Leij L and Mulder NH (1994) Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2. Br J Cancer 70: 652-661
12. Kroesen BJ, Bakker A, Van Lier RAW, The HT and de Leij L (1995) Bispecific antibody-mediated target cell-specific costimulation of resting T cells via CD5 and CD28. Cancer Res 55: 4409-4415
13. Leeuwenberg JF, Van Damme J, Meager T, Jeunhomme TM and Buurman WA (1988) Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells. Eur J Immunol 18: 1469-1472
14. Lou J, Dayer J, Grau G and Burger D (1996) Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells. Eur J Immunol 26: 3107-3113
15. Masinovsky B, Urdal D and Gallatin WM (1990) IL-4 acts synregistically with IL-1beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J Immunol 145: 2886-2895.
16. Molema G, de Leij LFMH and Meijer DKF (1997) Tumor vascular endothelium: barrier or target in tumor directed drug delivery and immunotherapy. Pharm Res 14: 2-10.
17. Molema G, Mesander G, Kroesen BJ, Helfrich W, Meijer DKF and de Leij LFMH (1998a) Analysis of in vitro lymphocyte adhesion and transendothelial migration by fluorescent heads based flow cytometric cell counting. Cytometry 32: 37-43.
18. Molema G, Meijer DKF and de Leij LFMH (1998b) Tumor vasculature targeted therapies: getting the players organized. Biochem Pharmacol 55: 1939-1945.
19. Morgan CD, Mills KC, Lefkowitz DL and Lefkowitz SS (1991) An improved colorimetric assay for tumor necrosis factor using WEHI 164 cells cultured on novel microtiter plates. J Immunol Methods 145: 259-262.
20. Mulder AB, Hegge Paping KS, Magielse CP, Blom NR, Smit JW, van der Meer J, Hallie MR and Bom VJ (1994) Tumor necrosis factor alpha-induced endothelial tissue factor is located on the cell surface rather than in the subendothelial matrix. Blood 84: 1559-1566.
21. Oppenheimer-Marks N, Davis LS, Tompkins Bogue D, Ramberg J and Lipsky PE (1991) Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol 147: 2913-2921.
22. Renner C, Bauer S, Sahin U, Jung W, van Lier R, Jacobs G, Held G and Pfreundschuh M (1996) Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical model. Blood 87: 2930-2937.
23. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314
24. Sunderkotter C, Steinbrink K, Henseleit U, Bosse R, Schwarz A, Vestweber D and Sorg C (1996) Activated T cells induce expression of E-selectin in vitro and in an antigen-dependent manner in vivo. Eur J Immunol 26: 1571-1579
25. Tax WJ, Willems HW, Reekers PP, Capel PJ and Koene RA (1983) Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature 304: 445-447
26. Thornhill MH, Kyan-Aung U and Haskard DO (1990) IL-4 increases human endothelial cell adhesiveness for T cells but nor for neutrophils. J Immunol 144: 3060-3065
27. 2+-dependent epitope stimulates lymphocyte adhesion. J Cell Biol 112: 345-354